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The reduction of methyl-CoM to methane in methanogenic bacteria is dependent on a low-Mr, heat-stable 
compound esignated component B, the structure of which has recently been assigned as N-7-mercaptohep- 
tanoyl-O-phosphothreonine. We report here that only the enantiomer derived from O-phospho-L-threonine 
has cofactor activity. N-7-Mercaptoheptanoyl-O-phospho-D-threonine was either active nor inhibitory. 
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1. INTRODUCTION 
Component B is a cofactor, required in 
methanogenesis [1,2]. Its structure has recently 
been assigned as N-7-mercaptoheptanoyl-O- 
phosphothreonine (7-mercaptoheptanoylthreonine 
phosphate, HS-HTP) [3,4]. The absolute con- 
figuration, however, has not yet been determined. 
O CH30 
II I II 
HS-CH2CH2CHzCH2CHzCH2C-NHCHCH-O-P-OH 
I I 
COOH OH 
HS-HTP 
The apparent Km for naturally occurring compo- 
nent B was found to be only half that for HS-HTP 
which had been chemically synthesized from 0- 
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phospho-DL-threonine and which was therefore a
racemic mixture of D- and L-HS-HTP [5,6]. This 
suggests that only one of the two enantiomers i
active. 
To confirm this assumption and to determine 
the absolute configuration of component B, we 
synthesized D- and L-HS-HTP and tested the ac- 
tivity of the two enantiomers a  cofactor in methyl- 
CoM reduction to methane as catalyzed by 
purified methyl-CoM reductase of Methano- 
bacterium thermoautotrophicum (strain Marburg) 
[71. 
2. MATERIALS AND METHODS 
D- and L-threonine (puriss., allo-free) and 
Amberlite IRC-84 ion-exchange resin (20-50 
mesh, H ÷ form, equilibrated with 2 M aqueous 
NH3 and washed with water) were from Fluka 
(Buchs, Switzerland). Kieselgel 60 thin-layer 
chromatography (TLC) plates (0.25 mm) were 
from Merck (Darmstadt); the plates were stained 
with ninhydrin (2O7o in n-butanol/2 M aqueous 
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acetic acid, 19: 1) or with PdC12 (0.5070 in H20). 
XAD-2 polystyrene adsorbent (0.1-0.2 mm) 
was from Serva (Heidelberg) and dithiothreitol 
(DTT) from Sigma (Miinchen). 
2.1. Synthesis of D- and L-HS-HTP 
2.1.1. O-Phospho-L- and D-threonine 
O-Phospho-L- and D-threonine were prepared 
by phosphorylation of L- and D-threonine, respec- 
tively, with POCI3 following the method of 
Neuhaus and Korkes [8]. O-Phospho-L-threonine: 
white crystals, m.p. 195°C after decomposition to 
a brown solid at 184°C; [a,] z3 = -7 .5  4- 0.2 ° (c = 
2.4 in HEO) in accordance with the value of - 7.4 ° 
(c = 2.6 in HzO) reported by De Verdier [9]. O- 
Phospho-D-threonine: m.p. 190°C (decomposi- 
tion at 184°C); [ot] 23 = +7.4 + 0.2 ° (c = 2.7 in 
H20). 
vacuum to 1/10 of the original volume and 
transferred onto a column of Amberlite IRC-84 
ion-exchange resin (8 g, 1.5 x 9 cm, NH~- form). 
After elution with H20 and lyophilization, 23 mg 
(20070) of a white solid was obtained. The prod- 
uct, ( - )-N,N '-(7,7 ' -dithiodiheptanoyl)bis(O- 
phospho-D-threonine) ([c~] 23 = -3 .4  + 0.5 °, c = 
2.3 in H20), was indistinguishable by TLC from a 
sample of racemic HTP-S-S-HTP prepared by the 
same method and characterized by 13C- and IH- 
NMR-spectroscopy. 
2.1.3. N-7-Mercaptoheptanoyl-O-phospho-L- 
threonine (L-HS-HTP) 
( + ) -N,N' - (7,7 ' -dithiodiheptanoyl)bis(O-phos- 
pho-L-threonine) ([O~'1 23 = -[-4.0 _+ 0.8 °, C = 0.8 in 
HzO) was obtained by the same procedure starting 
from O-phospho-L-threonine. 
2.1.2. N-7-Mercaptoheptanoyl-O-phospho-D- 
threonine (D-HS-HTP) 
The synthesis was carried out according to Noll 
et al. [6]. In contrast to [6], HS-HTP was not 
isolated as the free thiol but as the symmetrical 
disulfide (HTP-S-S-HTP), using the modified 
work-up procedure described below. 
A solution of O-phospho-D-threonine (86 mg, 
432/zmol) and triethylamine (120/zl, 861/~mol) in 
0.6 ml water was added with stirring to a solu- 
tion of 7,7'-dithiobis(succinimido-oxyheptano- 
ate) (77.5 mg, 150/zmol) [6] in 3.9 ml tetrahydro- 
furan and 0.9 ml acetonitrile. After stirring at 
room temperature under nitrogen for 36 h, the 
solvents were removed under vacuum at 30°C. The 
resulting white residue was dissolved in 1 M HC1 
(25 ml) and washed with dichloromethane (3 × 
8 ml). The aqueous phase was applied to a 2 × 
13 cm column of polystyrene XAD-2 (equilibrated 
with 1 M HCI). The column was washed with 
50 ml of 1 M HCI, followed by 80 ml H20. The 
product was eluted applying a methanol gradient 
(60 ml H20/MeOH,  4: 1; 100 ml H20/MeOH,  
1 : 1; 60 ml H20/MeOH,  1:4, 60 ml MeOH). TLC 
analysis (solvent system: n-butanol/acetic 
acid/HzO, 2:1 : 1) of the collected fractions (10 ml 
each) showed that HTP-S-S-HTP (Rf = 0.35) had 
been completely separated from O-phos- 
phothreonine (Rf = 0.24) and less polar prod- 
ucts (Rf > 0.6). The combined fractions containing 
pure HTP-S-S-HTP were concentrated under 
2.2. Assays for methyl-CoM reduction to methane 
All assays were performed in sealed 8-ml serum 
flasks as in [4,7]. The gas phase was Nz. The 0.4 ml 
assay mixture contained: 50 mM potassium 
phosphate buffer (pH 6.5); 15 mM DTT, 5.5 mM 
methyl-CoM, 150-300/~M hydroxycobalamin, 
0-50/¢g methyl-CoM reductase from M.  ther- 
moautotrophicum (strain Marburg), and synthetic 
HS-HTP or the disulfide thereof (0-2.2 mM). 
Methane formation was initiated by increasing the 
temperature from 22 to 60°C. 
3. RESULTS AND DISCUSSION 
Recently it was shown that purified methyl-CoM 
reductase from M. thermoautotrophicum (strain 
Marburg) catalyzes the reduction of methyl-CoM 
to methane with dithiothreitol in the presence of 
hydroxycobalamin a d a racemic mixture of syn- 
thetic D- and L-HS-HTP (apparent Km = 0.2 mM) 
[4]. Using the same assay conditions we now tested 
the D- and L-enantiomers for cofactor activity 
(fig.l). 
Methyl-CoM reduction to methane occurred on- 
ly in the presence of L-HS-HTP. An apparent Km 
of 0.07 mM and a maximal specific activity of 
460 nmol .min-~.mg protein-~ were found 
(fig.2A,B). D-HS-HTP showed no significant ac- 
tivity. At very high concentrations (2.2 raM) of the 
D-enantiomer methane was formed at only very 
low rates which could be due to contamination of 
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Fig. 1. Time course of methane formation from methyl- 
CoM in the presence of synthetic N-7-mercapto- 
heptanoyl-O-phosphothreonine (HS-HTP). The 400/zl 
assay contained 38/zg purified methyl-CoM reductase 
from M. thermoautotrophicum and 300/zM hydroxy- 
cobalamin. HS-HTP was applied in the disulfide form. 
(0) L-HS-HTP (0.1 mM), ( i )  D-HS-HTP (0.1 raM), 
(A) DL-HS-HTP (0.2 mM). 
the D-HS-HTP preparation by low amounts of  L- 
HS-HTP. This interpretation is supported by the 
finding that D-HS-HTP did not inhibit the action 
of L-HS-HTP, indicating that D-HS-HTP does 
not bind to the active site of  methyl-CoM reduc- 
tase (table 1). From these results we conclude that 
threonine has the L configuration in naturally oc- 
curring component B. 
The disulfide of HS-HTP can easily be purified 
under aerobic conditions and can therefore be 
prepared in a more homogeneous form than the 
corresponding reduced (oxygen-sensitive) thiol. 
Therefore, in the assays the disulfide was routinely 
applied. It presumably is rapidly reduced to HS- 
HTP under the assay conditions described (1 5 mM 
DTT, pH 6.5, 60°C). Indeed, the disulfide and 
HS-HTP exhibited the same cofactor activity (not 
shown). It should be pointed out, however, that 
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Fig.2. (A) Dependence of methyl-CoM reductase activity 
on concentration of L- (e) and D-HS-HTP (n). (B) 
Reciprocal plot of the data obtained for L-HS-HTP. 
The 400/d assay contained 23/zg purified methyl-CoM 
reductase from M. thermoautotrophicum, 150/zM 
hydroxycobalamin and 0-2.2 mM L- or D-HS-HTP 
(applied in the disulfide form). 
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Table 1 
Effect of D-HS-HTP on L-HS-HTP-dependent methane 
formation from methyI-CoM (assay conditions as 
described in the legend to fig.2) 
[L-HS-HTP] [D-HS-HTP] nmol CH4/min per 
(aM) (aM) mg protein 
0 0 0 
44 0 151 
0 llO 8 
44 110 156 
44 220 165 
110 0 208 
110 110 195 
this may not necessarily be the case when the 
reduction of methyl-CoM to CH4 with H2 as elec- 
tron donor is studied. Besides methyl-CoM reduc- 
tase reduction with HE requires the presence of at 
least three additional proteins (components A1-3), 
of FAD, Mg 2+, cobalamin, ATP and component B 
[10-13]. The assay is performed in a buffer con- 
taining low concentrations of mercaptoethanol. 
Under these conditions reduction of HTP-S-S- 
HTP is expected to be much slower than under the 
assay conditions for methyl-CoM reduction with 
DTT. 
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